Independent equity research
Company analysis, SEC filing changes and public follow-ups. Read the thesis, inspect the assumptions, and see what happened next.
Free research to read now. Premium research is coming.
New to LF0?
Understand a thesis. Compare a filing. Audit a call.
01 / Read a stock thesis
FormFactor (FORM) is rated Hold as strong AI-linked demand is offset by a valuation that already prices in much of the recovery. Q1 2026 showed revenue growth, but EBITDA softened…
Read the research02 / See what changed
Commercial Metals (CMC)'s MD&A section changed the most among 6 companies that filed 10-Ks on 16 October 2026, each compared against its prior-year filing.
Read the research03 / Check the follow-up
Revisiting our Sell call on PL: entry $16.42, latest $13.56, -17.4%.
Read the researchFrom the research desk
USA Rare Earth (USAR) earns a STRONG SELL rating as valuation races far ahead of operating reality. Revenue remains minimal while cash burn and massive capital needs keep the turnaround…
Read the researchMarathon Petroleum (MPC) is rated Hold as strong cash generation and 13.6% operating margin are already reflected in the share price. The case hinges on whether EBITDA and free cash…
Read the researchBoston Scientific (BSX) is rated Hold as strong organic growth and clinical momentum are offset by a valuation that already reflects much of the upside. The key question is whether…
Read the researchCommercial Metals (CMC)'s MD&A section changed the most among 6 companies that filed 10-Ks on 16 October 2026, each compared against its prior-year filing.
Read the researchComtech Telecommunications (CMTL)'s MD&A section changed the most among 3 companies that filed 10-Ks on 14 October 2026, each compared against its prior-year…
Read the researchLunai Bioworks (LNAI)'s Business section changed the most among 10 companies that filed 10-Ks on 13 October 2026, each compared against its prior-year filing.
Read the researchRevisiting our Sell call on PL: entry $16.42, latest $13.56, -17.4%.
Read the researchRevisiting our Sell call on MARA: entry $11.67, latest $7.53, -35.5%.
Read the researchRevisiting our Sell call on ASX: entry $41.63, latest $39.53, -5.0%.
Read the researchLF0 Research Desk
A rating is a thesis to examine. The original analysis and later scorecard reviews let you see both the reasoning and the outcome.
Stay connected
The current research is free to browse. The waitlist is for news about deeper premium analysis when it launches.
This form joins the LF0 premium waitlist. Substack is a separate subscription. You can read the current research without joining either.
Follow your interests
Explore more of the company analyses featured on LF0.